EvenUp Expands into Mass Torts

Diving deeper into

EvenUp

Company Report
it is extending beyond PI into mass tort, a move that broadens its TAM and lets it amortize R&D across adjacent plaintiff categories.
Analyzed 7 sources

Moving from PI into mass tort is less about adding one more feature, and more about turning a PI workflow engine into a broader plaintiff law operating system. The same core work, intake, medical record review, chronology building, demand drafting, and case triage, shows up in both categories, so a vendor can reuse models, verification workflows, and integrations across a larger revenue base. That is why mass tort expansion can raise TAM without forcing a full reset of the product stack.

  • Mass tort is a natural adjacency because the underlying inputs look similar. Firms still ingest client intake, provider records, bills, and liability facts, then turn them into structured case summaries and filing or settlement work product. Supio is already selling this crossover directly, positioning itself for both personal injury and mass tort firms.
  • The economic benefit is R&D leverage. Once a company has built extraction models, citation systems, human verification loops, and plaintiff specific workflows, it can spread those fixed costs across more case types. That is the same logic behind broader plaintiff platforms like Eve, which spans PI, employment, and other contingency fee matters at meaningful scale.
  • The strategic tradeoff is depth versus breadth. EvenUp stays more specialized in insurer facing PI work, treatment management, and pre lit operations, while broader rivals try to cover more plaintiff categories. At the same time, embedded platforms like Filevine are pushing AI into the case management layer, which raises the value of any specialist being able to cover more workflows and more matter types.

The market is heading toward plaintiff AI platforms that start in one high value workflow, then expand sideways into adjacent claim types and vertically into more of the case lifecycle. The winners are likely to be the vendors that can keep PI level accuracy while extending into mass tort, because that combination creates both a larger market and a stronger cost advantage over narrower point tools.